We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Celldex Therapeutics Inc | NASDAQ:CLDX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.64 | 4.01% | 42.50 | 42.00 | 96.25 | 42.98 | 41.34 | 41.91 | 605,345 | 05:00:01 |
Levi & Korsinsky announces it has commenced an investigation of Celldex Therapeutics, Inc. (NASDAQ: CLDX) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
On March 7, 2016, Celldex stock fell more than 50% on intraday trading following the Company’s disclosure that it will discontinue its late-stage study of RINTEGA. In a Company press release, Celldex noted that an independent Data Safety and Monitoring Board found that the trial will likely “not reach statistical significant for overall survival in patients with minimal residual disease, the primary end-point of the study.” To obtain additional information about this investigation, go to:
http://zlk.9nl.com/celldex-therapeutics-cldx
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160307006444/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
1 Year Celldex Therapeutics Chart |
1 Month Celldex Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions